Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BCTX	BRIACELL THERAPEUTICS CORP	$30.38M	-174.50%	-140.80%	-99.17%	-849.10%	0.11	10.10	N/A	N/A	N/A
GNPX	GENPREX INC	$7.87M	-464.10%	-275.50%	-203.26%	-12,857.60%	0.28	3.84	N/A	N/A	N/A
ACET	ADICET BIO INC	$82.05M	-83.00%	-68.00%	-68.36%	-87.70%	0.21	7.47	N/A	N/A	N/A
MNKD	MANNKIND CORP	$1.09B	N/A	-3.90%	1.85%	1.70%	-13.58	1.87	75.60%	-6.60%	3.12%
CNTN	CANTON STRATEGIC HOLDINGS INC	$171.10M	-35.60%	-27.10%	-8.16%	-34.00%	0.31	5.29	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$401.92M	-49.40%	-41.70%	-32.89%	-66.40%	0.25	18.55	100.00%	-214,861.00%	-212,531.71%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$188.88M	-60.20%	-54.50%	-50.31%	-284.40%	0.13	7.42	49.30%	-946.20%	-945.54%
CLNN	CLENE INC	$85.75M	N/A	-119.10%	-319.39%	-89.70%	-2.03	0.83	78.50%	-13,086.50%	-11,745.50%
CRVS	CORVUS PHARMACEUTICALS INC	$1.31B	-38.90%	-35.70%	-18.32%	-44.40%	0.05	19.81	N/A	N/A	N/A
NBP	NOVABRIDGE BIOSCIENCES	$253.97M	-20.90%	-19.40%	-19.80%	-73.60%	0.13	8.09	N/A	N/A	N/A
LGVN	LONGEVERON INC	$19.66M	-199.80%	-143.20%	-367.74%	-1,872.50%	0.81	1.33	67.00%	-1,893.60%	-1,893.58%
TRVI	TREVI THERAPEUTICS INC	$2.06B	-24.50%	-23.40%	-26.48%	-34.10%	0.04	24.75	N/A	N/A	N/A
VTGN	VISTAGEN THERAPEUTICS INC	$24.21M	-109.70%	-89.60%	-130.12%	-918.60%	0.28	4.68	100.00%	-8,486.80%	-8,486.84%
SLDB	SOLID BIOSCIENCES INC	$715.30M	-73.30%	-60.20%	-87.67%	-107.70%	0.29	6.14	N/A	N/A	N/A
DOMH	DOMINARI HOLDINGS INC	$82.31M	-21.90%	-18.00%	N/A	-14.20%	0.63	N/A	100.00%	-18.20%	-12.28%
NERV	MINERVA NEUROSCIENCES INC	$273.94M	N/A	-662.80%	-463.54%	-601.20%	-1.35	17.65	N/A	N/A	N/A
LTRN	LANTERN PHARMA INC	$23.63M	-150.80%	-108.40%	-262.00%	-330.40%	0.69	2.40	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$1.89B	-62.60%	-50.10%	-49.35%	-114.00%	0.20	5.96	100.00%	-8,253.30%	-8,199.34%
GENB	GENERATE BIOMEDICINES INC	$1.75B	N/A	N/A	N/A	N/A	0.22	9.17	N/A	N/A	N/A
GLUE	MONTE ROSA THERAPEUTICS INC	$1.64B	-41.00%	-25.90%	-19.82%	-39.40%	0.41	9.54	100.00%	-302.70%	-307.04%
TRDA	ENTRADA THERAPEUTICS INC	$265.53M	-51.20%	-42.20%	-52.21%	-48.90%	0.24	13.90	100.00%	-2,895.10%	-2,878.29%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$171.33M	-36.40%	-28.80%	-36.50%	-35.70%	0.27	8.46	N/A	N/A	N/A
AKBA	AKEBIA THERAPEUTICS INC	$311.18M	-62.70%	-5.70%	1.24%	5.70%	12.24	1.40	81.00%	-8.80%	1.01%
PHGE	BIOMX INC	$999.25k	-274.00%	-125.20%	5,947.65%	-207.00%	-5.44	0.87	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$467.10M	-27.80%	-26.30%	-22.59%	-38.20%	0.04	34.33	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.75B	-67.50%	-54.60%	-31.86%	-124.80%	0.16	9.01	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$494.68M	-36.50%	-35.40%	-42.15%	-44.50%	0.04	26.15	100.00%	-5,026.00%	-5,026.03%
HOWL	WEREWOLF THERAPEUTICS INC	$33.05M	-208.20%	-75.10%	-260.91%	-220.20%	3.76	1.27	N/A	N/A	N/A
QCLS	Q/C TECHNOLOGIES INC	$29.61M	-119.80%	-52.40%	-32.63%	-346.10%	0.76	3.00	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$294.30M	-64.90%	-30.20%	-30.25%	-35.60%	0.40	7.40	N/A	N/A	N/A
TNGX	TANGO THERAPEUTICS INC	$3.28B	-50.30%	-36.30%	-26.95%	-46.40%	0.15	16.32	100.00%	-162.90%	-162.85%
NMRA	NEUMORA THERAPEUTICS INC	$339.07M	-181.70%	-119.20%	-175.90%	-430.60%	1.18	5.10	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$25.93M	-372.20%	-153.70%	-335.71%	958.00%	7.62	2.63	N/A	N/A	N/A
SVRA	SAVARA INC	$1.07B	-84.00%	-63.60%	-50.99%	-66.30%	0.25	11.85	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$100.73M	-317.00%	-82.60%	-81.15%	-83.60%	1.50	2.71	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$1.48B	-32.50%	-30.90%	-34.26%	-101.90%	0.07	14.58	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$88.15M	-933.60%	-295.30%	3,230.75%	929.30%	-8.30	0.88	N/A	N/A	N/A
IVA	INVENTIVA SA	$1.04B	N/A	-192.20%	-79.70%	-87.70%	-9.75	3.16	100.00%	-4,468.10%	-1,730.94%
RCUS	ARCUS BIOSCIENCES INC	$3.19B	-69.00%	-35.30%	-45.56%	-51.60%	0.90	4.04	100.00%	-156.40%	-152.12%
COGT	COGENT BIOSCIENCES INC	$5.94B	-83.30%	-55.80%	-41.42%	-67.00%	0.49	15.14	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$1.76B	-54.30%	-40.60%	-46.65%	-311.60%	0.31	5.47	7.20%	-842.90%	-849.83%
ELAB	PMGC HOLDINGS INC	$61.39k	-92.50%	-67.30%	-83.57%	-428.70%	0.64	1.74	31.40%	-1,313.00%	-1,264.09%
GHRS	GH RESEARCH PLC	$1.33B	-16.30%	-15.80%	-17.08%	-99.00%	0.03	34.13	N/A	N/A	N/A
SDEV	STABLECOIN DEVELOPMENT CORP	$43.40M	N/A	-8,609.90%	-7,991.64%	-188,433.20%	-1.01	7.60	N/A	N/A	N/A
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$194.39M	-65.80%	-57.90%	-53.24%	-80.20%	0.14	8.07	N/A	N/A	N/A
IMMX	IMMIX BIOPHARMA INC	$530.51M	-73.20%	-59.20%	-40.99%	8,512.30%	0.14	8.76	N/A	N/A	N/A
OCGN	OCUGEN INC	$511.17M	-127,987.50%	-135.50%	-184.13%	-177.20%	8.80	1.86	100.00%	-1,605.20%	-1,492.70%
DFTX	DEFINIUM THERAPEUTICS INC	$2.40B	-102.50%	-70.70%	-72.28%	-153.80%	0.44	4.69	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$1.64B	-55.70%	-50.70%	-54.05%	-158.90%	0.08	17.85	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$6.52B	-31.20%	-27.80%	-26.43%	-36.20%	0.14	8.97	N/A	N/A	N/A
CBUS	CIBUS INC	$99.64M	-236.80%	-38.60%	-31.78%	-33.10%	12.97	0.72	100.00%	-3,492.30%	-2,516.49%
OCUL	OCULAR THERAPEUTIX INC	$2.11B	-64.60%	-48.40%	-40.72%	-296.40%	0.26	14.81	87.20%	-558.20%	-535.90%
AVIR	ATEA PHARMACEUTICALS INC	$432.62M	-46.30%	-42.50%	-59.73%	-65.00%	0.14	7.82	N/A	N/A	N/A
FBLG	FIBROBIOLOGICS INC	$6.04M	-767.10%	-195.60%	-449.55%	-376.50%	1.28	1.59	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$17.47M	-411.00%	-275.60%	-661.53%	1,138.50%	0.59	2.68	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$80.09M	-797.20%	-201.80%	-578.97%	405.50%	3.09	1.66	N/A	N/A	N/A
MBRX	MOLECULIN BIOTECH INC	$13.18M	N/A	-158.30%	-219.75%	808.30%	0.47	1.41	N/A	N/A	N/A
PVLA	PALVELLA THERAPEUTICS INC	$1.74B	-56.90%	-42.50%	-16.46%	-633.60%	0.14	28.88	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$5.77B	-36.80%	-34.90%	-28.11%	-43.00%	0.04	26.57	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$9.20B	-43.00%	-40.20%	-23.16%	-71.10%	0.04	15.88	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$76.88M	-237.50%	-146.00%	-99.14%	1,341.30%	0.23	6.63	N/A	N/A	N/A
CLDX	CELLDEX THERAPEUTICS INC	$2.67B	-50.70%	-46.60%	-61.69%	-55.90%	0.12	8.92	100.00%	-32,753.60%	-32,753.58%
XENE	XENON PHARMACEUTICALS INC	$5.46B	-49.20%	-46.40%	-28.59%	-70.10%	0.04	27.79	N/A	N/A	N/A
MLYS	MINERALYS THERAPEUTICS INC	$2.44B	-27.90%	-27.00%	-23.78%	-38.70%	0.02	44.33	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$132.82M	-48.90%	-37.60%	-29.28%	-851.60%	0.28	8.65	81.30%	-202.20%	-202.24%
PASG	PASSAGE BIO INC	$13.50M	-135.00%	-60.40%	-116.13%	-188.10%	2.32	2.07	N/A	N/A	N/A
IMNM	IMMUNOME INC	$2.54B	-57.60%	-52.40%	-33.28%	-472.30%	0.08	14.69	100.00%	-3,060.00%	-3,059.99%
TSHA	TAYSHA GENE THERAPIES INC	$1.96B	-56.10%	-40.20%	-46.32%	-220.10%	0.42	14.04	100.00%	-1,738.40%	-1,737.69%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$613.05M	-85.90%	-41.90%	-32.43%	-143.60%	0.09	12.34	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.71B	-60.70%	-50.60%	-47.85%	-65.40%	0.24	15.15	100.00%	-508.50%	-497.44%
ALDX	ALDEYRA THERAPEUTICS INC	$104.36M	-57.30%	-36.30%	-60.44%	-576.70%	0.58	2.72	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$151.32M	-179.40%	-117.50%	-137.29%	-1,099.30%	0.31	0.78	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$1.29B	-40.70%	-36.00%	-35.01%	-130.70%	0.12	15.50	N/A	N/A	N/A
CMPX	COMPASS THERAPEUTICS INC	$329.56M	-39.70%	-35.30%	-34.98%	-45.10%	0.10	19.04	N/A	N/A	N/A
NKTX	NKARTA INC	$227.42M	-30.00%	-23.80%	-27.25%	-23.60%	0.29	12.69	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$200.52M	-51.80%	-49.50%	-54.19%	2,649.80%	0.07	14.57	N/A	N/A	N/A
CING	CINGULATE INC	$61.28M	-515.30%	-174.30%	-471.57%	-717.00%	5.01	1.16	N/A	N/A	N/A
KRRO	KORRO BIO INC	$173.79M	-117.90%	-71.00%	-66.79%	-73.30%	0.54	8.13	100.00%	-2,954.10%	-2,935.09%
RVMD	REVOLUTION MEDICINES INC	$30.15B	-83.20%	-59.10%	-67.98%	-65.20%	0.50	6.80	N/A	N/A	N/A
ABSI	ABSCI CORP	$919.84M	-63.60%	-54.70%	-67.32%	-92.70%	0.14	6.59	100.00%	-6,450.80%	-6,437.75%
BNTC	BENITEC BIOPHARMA INC	$421.87M	-38.90%	-37.70%	-23.66%	4,739.40%	0.02	67.69	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$866.46M	-38.50%	-29.40%	-18.11%	-41.50%	0.12	10.38	100.00%	-174.80%	-165.74%
IKT	INHIBIKASE THERAPEUTICS INC	$271.99M	-46.90%	-43.50%	-27.91%	-232.50%	0.05	21.70	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$209.41M	15.20%	12.50%	8.34%	15.10%	0.14	9.46	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$5.88B	-22.90%	-21.80%	-21.16%	-23.90%	0.05	24.63	-15.00%	-3,985.00%	-3,985.02%
QNCX	QUINCE THERAPEUTICS INC	$20.87M	N/A	-78.50%	-160.58%	-294.90%	-3.62	0.53	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$396.37M	-70.80%	-59.60%	-79.52%	-94.90%	0.20	6.12	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.11B	-52.20%	-43.90%	-43.94%	-54.40%	0.37	9.29	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$5.80B	-163.50%	-96.70%	-84.39%	-216.20%	0.94	8.64	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$1.30B	-42.90%	-38.70%	-33.73%	-48.00%	0.12	9.95	N/A	N/A	N/A
ARVN	ARVINAS INC	$646.65M	-14.30%	-9.30%	-13.99%	-13.40%	0.66	4.92	100.00%	-30.80%	-30.65%
ENGN	ENGENE THERAPEUTICS INC	$100.48M	-55.80%	-45.70%	-38.23%	-51.90%	0.20	11.75	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$386.95M	-69.20%	-66.80%	-47.92%	-20,841.50%	0.07	15.12	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$254.15M	N/A	-45.90%	-59.08%	-107.40%	-2.95	7.65	100.00%	-8,698.70%	-9,068.56%
ZURA	ZURA BIO LTD	$455.04M	-76.80%	-65.90%	-34.39%	568.20%	0.05	19.33	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$561.56M	N/A	-18.80%	-22.49%	-28.20%	-0.03	9.13	100.00%	-7,725.20%	-7,678.39%
OSRH	OSR HOLDINGS INC	$18.91M	-33.90%	-15.30%	-18.42%	312.80%	0.57	0.16	20.40%	-931.20%	-977.14%
PHIO	PHIO PHARMACEUTICALS CORP	$12.43M	-77.30%	-70.90%	-66.41%	1,458.10%	0.06	18.32	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.61B	-36.90%	-33.90%	-33.06%	-39.40%	0.09	24.00	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$277.38M	-204.10%	-121.40%	-164.57%	-330.20%	0.94	4.39	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 27, which is 2 points higher than the biotech industry average of 25.

JAZZ passed 9 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 129.44% over the past year, overperforming other biotech stocks by 132 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $237.67, an upside of 5.26% from Jazz Pharmaceuticals's current stock price of $225.79.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 58.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 52, which is 27 points higher than the biotech industry average of 25.

EXEL passed 17 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 31.95% over the past year, overperforming other biotech stocks by 34 percentage points.

Exelixis has an average 1 year price target of $48.00, a downside of -0.33% from Exelixis's current stock price of $48.16.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 14.29% have issued a Strong Buy rating, 14.29% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 56, which is 31 points higher than the biotech industry average of 25.

PBYI passed 18 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 143.97% over the past year, overperforming other biotech stocks by 146 percentage points.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 18.27%, which is 14 percentage points higher than the biotech industry average of 4.3%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.11%, which is 2 percentage points higher than the biotech industry average of 4.3%.

Oramed Pharmaceuticals's dividend payout ratio of 16.3% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.77%, which is -2 percentage points lower than the biotech industry average of 4.3%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 43.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.17% in the last day, and up 2.15% over the last week. Traws Pharma was the among the top gainers in the biotechnology industry, gaining 28.24% yesterday.

Traws Pharma shares are trading higher after the company announced plans to advance potential clinical candidates for the treatment of hantavirus infections.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Rigel Pharmaceuticals has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Rigel Pharmaceuticals's stock has gained 37.78% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 65.01% in the past year. It has overperformed other stocks in the biotech industry by 67 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -9.09% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

65.08% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 61.11% over the next year.

3.09% of biotech stocks have a Zen Rating of A (Strong Buy), 3.75% of biotech stocks are rated B (Buy), 47.46% are rated C (Hold), 34.44% are rated D (Sell), and 11.26% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.13x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.